Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Differential electrophysiological changes in striatal output neurons in Huntington's disease.

André VM, Cepeda C, Fisher YE, Huynh M, Bardakjian N, Singh S, Yang XW, Levine MS.

J Neurosci. 2011 Jan 26;31(4):1170-82. doi: 10.1523/JNEUROSCI.3539-10.2011.

2.

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease.

André VM, Fisher YE, Levine MS.

Front Syst Neurosci. 2011 Jun 16;5:46. doi: 10.3389/fnsys.2011.00046. eCollection 2011.

3.

Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.

Cepeda C, André VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS.

Eur J Neurosci. 2008 Feb;27(3):671-82. doi: 10.1111/j.1460-9568.2008.06038.x.

PMID:
18279319
4.

Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids.

André VM, Cepeda C, Cummings DM, Jocoy EL, Fisher YE, William Yang X, Levine MS.

Eur J Neurosci. 2010 Jan;31(1):14-28. doi: 10.1111/j.1460-9568.2009.07047.x. Epub 2009 Dec 21.

PMID:
20092552
5.

Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons.

Ma YY, Cepeda C, Chatta P, Franklin L, Evans CJ, Levine MS.

ASN Neuro. 2012 Mar 8;4(2). pii: e00077. doi: 10.1042/AN20110063.

6.

Membrane properties of striatal direct and indirect pathway neurons in mouse and rat slices and their modulation by dopamine.

Planert H, Berger TK, Silberberg G.

PLoS One. 2013;8(3):e57054. doi: 10.1371/journal.pone.0057054. Epub 2013 Mar 1.

7.

Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease.

Galvan L, André VM, Wang EA, Cepeda C, Levine MS.

J Huntingtons Dis. 2012;1(1):17-25. doi: 10.3233/JHD-2012-120009. Review.

8.

Differential Synaptic and Extrasynaptic Glutamate-Receptor Alterations in Striatal Medium-Sized Spiny Neurons of Aged YAC128 Huntington's Disease Mice.

Botelho EP, Wang E, Chen JY, Holley S, Andre V, Cepeda C, Levine MS.

PLoS Curr. 2014 May;6. pii: ecurrents.hd.34957c4f8bd7cb1f5ec47381dfc811c3. doi: 10.1371/currents.hd.34957c4f8bd7cb1f5ec47381dfc811c3.

9.

Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.

Zhang J, Saur T, Duke AN, Grant SG, Platt DM, Rowlett JK, Isacson O, Yao WD.

J Neurogenet. 2014 Mar-Jun;28(1-2):98-111. doi: 10.3109/01677063.2014.892486. Epub 2014 Apr 22.

10.

Facilitated glutamatergic transmission in the striatum of D2 dopamine receptor-deficient mice.

Cepeda C, Hurst RS, Altemus KL, Flores-Hernández J, Calvert CR, Jokel ES, Grandy DK, Low MJ, Rubinstein M, Ariano MA, Levine MS.

J Neurophysiol. 2001 Feb;85(2):659-70.

11.

Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors.

Fasano C, Bourque MJ, Lapointe G, Leo D, Thibault D, Haber M, Kortleven C, Desgroseillers L, Murai KK, Trudeau LÉ.

Neuropharmacology. 2013 Apr;67:432-43. doi: 10.1016/j.neuropharm.2012.11.030. Epub 2012 Dec 8.

PMID:
23231809
12.

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.

Tang TS, Chen X, Liu J, Bezprozvanny I.

J Neurosci. 2007 Jul 25;27(30):7899-910.

14.

Dopamine enhancement of NMDA currents in dissociated medium-sized striatal neurons: role of D1 receptors and DARPP-32.

Flores-Hernández J, Cepeda C, Hernández-Echeagaray E, Calvert CR, Jokel ES, Fienberg AA, Greengard P, Levine MS.

J Neurophysiol. 2002 Dec;88(6):3010-20.

15.

Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism.

Warre R, Thiele S, Talwar S, Kamal M, Johnston TH, Wang S, Lam D, Lo C, Khademullah CS, Perera G, Reyes G, Sun XS, Brotchie JM, Nash JE.

Neurobiol Dis. 2011 Mar;41(3):591-604. doi: 10.1016/j.nbd.2010.10.013. Epub 2010 Oct 21.

PMID:
20971190
16.

Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.

Cummings DM, Cepeda C, Levine MS.

ASN Neuro. 2010 Jun 18;2(3):e00036. doi: 10.1042/AN20100007.

17.

Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine.

Ellender TJ, Huerta-Ocampo I, Deisseroth K, Capogna M, Bolam JP.

J Neurosci. 2011 Oct 26;31(43):15340-51. doi: 10.1523/JNEUROSCI.3144-11.2011.

18.
19.

Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons.

Alberto CO, Trask RB, Quinlan ME, Hirasawa M.

J Neurosci. 2006 Sep 27;26(39):10043-50. Retraction in: J Neurosci. 2012 Jun 27;32(26):9116.

20.

Dopamine-dependent long-term depression is expressed in striatal spiny neurons of both direct and indirect pathways: implications for Parkinson's disease.

Bagetta V, Picconi B, Marinucci S, Sgobio C, Pendolino V, Ghiglieri V, Fusco FR, Giampà C, Calabresi P.

J Neurosci. 2011 Aug 31;31(35):12513-22. doi: 10.1523/JNEUROSCI.2236-11.2011.

Items per page

Supplemental Content

Write to the Help Desk